Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance

被引:0
|
作者
Kimura, Hirokazu [1 ]
Paranal, Raymond M. [1 ,2 ]
Nanda, Neha [1 ]
Wood, Laura D. [1 ,3 ]
Eshleman, James R. [1 ,3 ,4 ]
Hruban, Ralph H. [1 ,3 ]
Goggins, Michael G. [1 ,3 ]
Klein, Alison P. [1 ,3 ,4 ]
Roberts, Nicholas J. [1 ,3 ]
机构
[1] Johns Hopkins Univ, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Human Genet Predoctoral Training Program, McKusick Nathans Inst Genet Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA
来源
ELIFE | 2022年 / 11卷
基金
美国国家卫生研究院;
关键词
pancreas; cancer; familial cancer; CDKN2A; variant of uncertain significance; pancreatic ductal adenocarcinoma; Human; GERM-LINE MUTATIONS; PANCREATIC-CANCER; SOMATIC MUTATIONS; RISK; ASSOCIATION; GENES;
D O I
10.7554/eLife.71137; 10.7554/eLife.71137.sa1; 10.7554/eLife.71137.sa2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Pathogenic germline CDKN2A variants are associated with an increased risk of pancreatic ductal adenocarcinoma (PDAC). CDKN2A variants of uncertain significance (VUSs) are reported in up to 4.3% of patients with PDAC and result in significant uncertainty for patients and their family members as an unknown fraction are functionally deleterious, and therefore, likely pathogenic. Functional characterization of CDKN2A VUSs is needed to reclassify variants and inform clinical management. Twenty-nine germline CDKN2A VUSs previously reported in patients with PDAC or in ClinVar were evaluated using a validated in vitro cell proliferation assay. Twelve of the 29 CDKN2A VUSs were functionally deleterious (11 VUSs) or potentially functionally deleterious (1 VUS) and were reclassified as likely pathogenic variants. Thus, over 40% of CDKN2A VUSs identified in patients with PDAC are functionally deleterious and likely pathogenic. When incorporating VUSs found to be functionally deleterious, and reclassified as likely pathogenic, the prevalence of pathogenic/likely pathogenic CDKN2A in patients with PDAC reported in the published literature is increased to up to 4.1% of patients, depending on family history. Therefore, CDKN2A VUSs may play a significant, unappreciated role in risk of pancreatic cancer. These findings have significant implications for the counselling and care of patients and their relatives.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A:: correlation with protein structure information
    Ruas, M
    Brookes, S
    McDonald, NQ
    Peters, G
    ONCOGENE, 1999, 18 (39) : 5423 - 5434
  • [22] A Flexible Multiplex Bead-Based Assay for Detecting Germline CDKN2A and CDK4 Variants in Melanoma-Prone Kindreds
    Lang, Julie M.
    Shennan, Michael
    Njauw, Jenny C. -N.
    Luo, Su
    Bishop, Julia N.
    Harland, Mark
    Hayward, Nicholas K.
    Tucker, Margaret A.
    Goldstein, Alisa M.
    Landi, Maria T.
    Puig, Susana
    Gruis, Nelleke A.
    Bergman, Wilma
    Bianchi-Scarra, Giovanna
    Ghiorzo, Paola
    Hogg, David
    Tsao, Hensin
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (02) : 480 - 486
  • [23] Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules
    Jimenez-Sainz, Judit
    Jensen, Ryan B.
    GENES, 2021, 12 (05)
  • [24] Identification of deleterious variants of uncertain significance in BRCA2 BRC4 repeat through molecular dynamics simulations
    Sinha, Siddharth
    Qin, Zixin
    Tam, Benjamin
    Wang, San Ming
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2022, 21 (03) : 202 - 215
  • [25] Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information
    Margarida Ruas
    Sharon Brookes
    Neil Q McDonald
    Gordon Peters
    Oncogene, 1999, 18 : 5423 - 5434
  • [26] Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2
    Wu, Shijie
    Qi, Lina
    Chen, Huihui
    Zhang, Kun
    He, Jiapan
    Guo, Xianan
    Shen, Lu
    Zhou, Yunxiang
    Zhong, Xi
    Zheng, Shu
    Zhou, Jiaojiao
    Chen, Yiding
    NPJ BREAST CANCER, 2022, 8 (01)
  • [27] Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2
    Shijie Wu
    Lina Qi
    Huihui Chen
    Kun Zhang
    Jiapan He
    Xianan Guo
    Lu Shen
    Yunxiang Zhou
    Xi Zhong
    Shu Zheng
    Jiaojiao Zhou
    Yiding Chen
    npj Breast Cancer, 8
  • [28] An Efficient Pipeline for the Generation and Functional Analysis of Human BRCA2 Variants of Uncertain Significance
    Hendriks, Giel
    Morolli, Bruno
    Calleja, Fabienne M. G. R.
    Plomp, Anouk
    Mesman, Romy L. S.
    Meijers, Matty
    Sharan, Shyam K.
    Vreeswijk, Maaike P. G.
    Vrieling, Harry
    HUMAN MUTATION, 2014, 35 (11) : 1382 - 1391
  • [29] Functional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited Cardiomyocytes
    Lv, Wenjian
    Qiao, Lyon
    Petrenko, Nataliya
    Li, Wenjun
    Owens, Anjali T.
    McDermott-Roe, Chris
    Musunuru, Kiran
    CIRCULATION, 2018, 138 (24) : 2852 - 2854
  • [30] BRCA1/2 mutation analysis in Indonesian hereditary breast cancer revealed frequent variants of uncertain significance
    Haryono, S.
    Utami, S.
    ANNALS OF ONCOLOGY, 2016, 27